SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/24A872ED0A26FE1CED5965F82557F4E2F291E2842B94AA3384CBD9D4F854E022D873427EC157ECAA5D7330F74834690A>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/24A872ED0A26FE1CED5965F82557F4E2F291E2842B94AA3384CBD9D4F854E022D873427EC157ECAA5D7330F74834690A
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/24A872ED0A26FE1CED5965F82557F4E2F291E2842B94AA3384CBD9D4F854E022D873427EC157ECAA5D7330F74834690A
http://www.w3.org/2000/01/rdf-schema#comment
"Studies provide evidence that LYVE-1.hyaluronan axis mediates leucocyte docking and entry to lymphatic vessels advancing the understanding about not just of LYVE-1 itself but also lymphatic trafficking in general. (review)"
xsd:string
http://purl.uniprot.org/uniprot/#_50A06403FA93F48B0060BB25B7A9A05051E4F31E5096D349A696CF780FA54E37D982A0FE5A30BB3B09E51FD6EB930EB1
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/24A872ED0A26FE1CED5965F82557F4E2F291E2842B94AA3384CBD9D4F854E022D873427EC157ECAA5D7330F74834690A
http://purl.uniprot.org/uniprot/Q9Y5Y7
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/24A872ED0A26FE1CED5965F82557F4E2F291E2842B94AA3384CBD9D4F854E022D873427EC157ECAA5D7330F74834690A
http://purl.uniprot.org/uniprot/#_Q9Y5Y7-mappedCitation-29425695
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/24A872ED0A26FE1CED5965F82557F4E2F291E2842B94AA3384CBD9D4F854E022D873427EC157ECAA5D7330F74834690A